Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00846560

Enrollment

Registered

2009-02-18

Start date

2008-08-31

Completion date

2009-07-31

Last updated

2017-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

Brief summary

The involvement of Lymphocyte type B in Amyotrophic lateral sclerosis (ALS) patients will be compared to lymphocyte in healthy subjects.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Yes

Inclusion criteria

* ALS patients who could sign ICF.

Exclusion criteria

* No ALS patients age less than 18 years.

Countries

Israel

Outcome results